Antihypertensive effects of angiotensin-(1-7)

Brazilian Journal of Medical and Biological Research

Volumn 31, Issue 9, 1998, Pages 1205-1212

  Chappell, M C ^a   Iyer, S N ^a   Diz, D I ^a   Ferrario, C M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Angiotensin (1 7); Hypertension

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN RECEPTOR; ANGIOTENSIN[1-7]; ATRIAL NATRIURETIC FACTOR; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE; MEMBRANE METALLOENDOPEPTIDASE; NITRIC OXIDE; PROSTAGLANDIN; PROTEINASE; UNCLASSIFIED DRUG; VASOPRESSIN;

ANTIHYPERTENSIVE ACTIVITY; CARDIOVASCULAR AUTOREGULATION; CONFERENCE PAPER; DIURESIS; NATRIURESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0031732267     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1998000900014     Document Type: Conference Paper

References (51)

1. Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB & Diz DI (1997). Counter-regulatory actions of angiotensin-(1-7). Hypertension, 30: 535-541.
2. Welches WR, Brosnihan KB & Ferrario CM (1993). A comparison of the properties, and enzymatic activity of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24. 11. Life Sciences, 52: 1461-1480.
3. 2 receptors in the plasma clearance of angiotensin II. Journal of Cardiovascular Pharmacology (in press).
4. Vernace MA, Mento PF, Maita ME & Wilkes BM (1994). Effects of angiotensin receptor subtype inhibitors on plasma angiotensin clearance Hypertension. 23: 853-856.
5. Chappell MC, Pirro NT, Sykes A & Ferrario CM (1998). Metabolism of angiotensin-(1-7) by angiotensin converting enzyme Hypertension, 31: 362-367.
6. 1-7 and Keto-ACE. Hyperension, 30: 494 (Abstract).
7. Li P, Chapoell MC, Ferrario CM & Brosnihan KB (1997). Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension, 29: 394-400.
8. Wei L, Caluser E, Alnenc-Gelas F & Corvol P (1992). The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. Journal of Biological Chemistry, 267: 13398-13405.
9. Deddish PA, Wang LX, Jackman HL, Michel B, Wang J, Skidgel RA & Erdos EG (1996). Single-angiotensin I-converting enzyme (kininase II): characterization and properties. Journal of Pharmacology and Experimental Therapeutics, 279: 1582-1589.
10. Yamada K, Iyer SN, Chappell MC, Ganten D & Ferrario CM (1998). Converting enzyme determines the plasma clearance of angiotensin-(1-7). Hypertension (in press).
11. Schiavone MT, Santos RAS, Brosnihan KB, Khosla MC & Ferrario CM (1988). Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide. Proceedings of the National Academy of Sciences, USA, 85: 4095-4098.
12. Santos RAS, Silva ACS, Magaldi AJ, Khosla MC, Ceasr KR, Passaglio KT & Baracho NCV (1996). Evidence for a physiological role of angiotensin-(1-7) in the control of hydroelectrolyte balance. Hypertension, 27: 875-884.
13. Campagnole-Santos MJ, Heringer SB, Batista EN, Khosla MC & Santos RAS (1992). Differential baroreceptor reflex modulation by centrally infused angiotensin peptides. American Journal of Physiology, 263: R89-R94.
14. Silva LCS, Fontes MAP, Campagnole-Santos MJ, Khosla MC, Campos Jr RR, Guertzenstein PG & Santos RAS (1993). Cardiovascular effects produced by micro-injection of angiotensin-(1-7) on vasopressor and vasodepressor sites of the ventrolateral medulla. Brain Research. 613: 321-325.
15. Campagnole-Santos MJ, Diz DI, Santos RAS, Khosla MC, Brosnihan KB & Ferrario CM (1989). Cardiovascular effects of angiotensin-(1-7) injected into the dorsal medulla of rats. American Journal of Physiology, 257: H324-H329.
16. Mahon JM, Allen M, Herbert J & Fitzsimons JT (1995). The association of thirst, sodium appetite and vasopressin release with c-fos expression in the forebrain of the rat after intracerebroventricular injection of angiotensin II, angiotensin-(1-7) or carbachol. Neuroscience Letters, 69: 199-208.
17. Jaiswal N, Diz DI. Chappell MC, Khosla MC & Ferrario CM (1992). Stimulation of endothelial cell prostaglandin production by angiotensin peptides. Hypertension, 19 (Suppl II): 49-55.
18. Jaiswal N, Tallant EA, Jaiswal RK, Diz DI & Ferrario CM (1993). Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: Subtypes of angiotensin receptors involved. Journal of Pharmacology and Experimental Therapeutics, 265: 664-673.
19. Benter IF, Ferrario CM, Morris M & Diz DI (1995) Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. American Journal of Physiology, 269: H313-H319.
20. Jaiswal N. Jaiswal RK, Tallant EA, Diz DI & Ferrario CM (1993). Alterations in prostaglandin production in spontaneously hypertensive rat smooth muscle cells. Hypertension, 21: 900-905.
21. Trachte GJ, Ferrario CM & Khosla MC (1990). Selective blockade of angiotensin responses in the rabbit isolated vas deferens by angiotensin receptor antagonists. Journal of Pharmacology and Experimental Therapeutics, 255: 929-934.
22. Lima CV, Paula RD, Resende FL, Khosla MC & Santos RAS (1997). Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1-7) in normotensive and hypertensive rats. Hypertension, 30: 542-548.
23. Paula RD, Lima CV, Khosla MC & Santos RAS (1995). Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats. Hypertension, 26: 1154-1159.
24. Abbas A, Gorelik G, Carbini LA & Scicli AG (1997). Angiotensin-(1-7) induces bradykinin-mediated hypotensive responses in anesthetized rats. Hypertension, 30: 217-221.
25. Porsti I, Bara AT, Busse R & Hecker M (1994). Release of nitric oxide by anciotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor British Journal of Pharmacology, 111: 652-654.
26. Osei SY, Ahima RS, Minkes RK, Weaver JP, Khosla MC & Kadowitz PJ (1993). Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds. European Journal of Pharmacology, 234: 35-42.
27. Benter IF, Diz DI & Ferrario CM (1993). Cardiovascular actions of angiotensin-(1-7). Peptides, 14: 679-684.
28. Benter IF, Diz DI & Ferrario CM (1995). α-Adrenergic and angiotensin II pressor responses are reduced in angiotensin-(1-7)-treated spontaneously hypertensive rats. Hypertension, 25: 1416 (Abstract).
29. Chappell MC, Tallant EA, Brosnihan KB & Ferrario CM (1994). Conversion of angiotensin I to angiotensin-(1-7) by thimet oligopeptidase (EC 3.4.24.15) in vascular smooth muscle cells. Journal of Vascular Medicine and Biology, 5: 129-137.
30. Erdos EG (1990). Angiotensin I converting enzyme and the charges in our concepts through the years Hypertension, 16: 363-370.
31. Biollaz J, Brunner HR, Gavras I, Waeber B & Gavras H (1982). Antihypertensive therapy with MK 421: angiotensin II-renin relationships to evaluate efficacy of converting enzyme blockade Journal of Cardiovascular Pharmacology, 4: 966-972.
32. Brunner HR, Gavras H, Turini GA, Waeber B, Chappuis P & McKinstry DN (1978). Long term treatment of hypertension in man by an orally active angiotensin-converting enzyme inhibitor Clinical Science and Molecular Medicine, 55: 2934-2959.
33. Carretero OA, Miyazaki S & Scicli AG (1981). Role of kinins in the acute antihypertensive activity of the converting enzyme inhibitor, captopril. Hypertension, 3: 18-22.
34. Cachofeiro V, Maeso R, Rodrigo E, Navarro J, Ruilope LM & Lahera V (1995). Nitric oxide and prostaglandins in the prolonged effects of losartan and ramipril in hypertension Hypertension, 26: 236-243.
35. Bao G, Gohlke P & Unger T (1992). Role of bradykinin in chronic antihypertensive actions of ramipril in different hypertension models. Journal of Cardiovascular Pharmacology, 20: S96-S99.
36. Iyer SN, Ferrario CM & Chappell MC (1998). Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system. Hypertension, 31: 356-361.
37. Yamamoto K, Chappell MC, Brosnihan KB & Ferrario CM (1992). In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertension, 19: 692-696.
38. Iyer SN, Chappell MC, Averill DB, Diz DI & Ferrario CM (1998). Vasodepressor actions of angiotensin-(1-7) unmasked durng combined treatment with lisinopril and losartan. Hypertension, 31: 699-705.
39. Tallant EA, Lu X, Weiss RB, Chappell MC & Ferrario CM (1997). Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension, 29: 388-392.
40. Tallant EA, Diz DI, Khosla MC & Ferrario CM (1991). Identification and regulation of angiotensin II receptor subtypes on NG108-15 cells. Hypertension, 17: 1135-1143.
41. DelliPizzi A, Hilchey SD & Bell-Quilley CP (1994). Natriuretic actions of angiotensin-(1-7). British Journal of Pharmacology, 111: 1-3.
42. Heyne N, Beer W, Muhlbauer B & Osswald H (1995). Renal response to angiotensin (1-7) in anesthetized rats Kidney International, 47: 975-976 (Abstract).
43. Handa RK, Ferrario CM & Strandhoy JW (1996). Renal actions of angiotensin-(1-7) in vivo and in vitro studies. American Journal of Physiology, 270: F141-F147.
44. 2 release. Hypertension, 25: 1238-1244.
45. Andreatta-Van Leyen S, Romero MF, Khosla MC & Douglas JG (1993). Modulation of phospholipase A2 activity and sodium transport by angiotensin-(1-7). Kidney International, 44: 932-936.
46. Stephenson SL & Kenny AJ (1987). Metabolism of neuropeptides. Biochemistry Journal, 241: 237-247.
47. Garcia NH & Garvin JL (1994). Angiotensin 1-7 has a biphasic effect on fluid absorption in the proximal straight tubule. Journal of the American Society of Nephrology, 5 1133-1138.
48. Santos RAS & Baracho NCV (1992). Angiotensin-(1-7) is a potent anti-diuretic peptide in rats Brazilian Journal of Medical and Biological Research, 25: 651-654.
49. Baracho NCV, Silva ACE, Khosla MC & Santos RAS (1995). Characterization of the anti-diuretic action of angiotensin-(1-7) in water-loaded rats Hypertension, 25: 1408 (Abstract).
50. Santos RAS, Campagnole-Santos MJ, Baracho NCV, Fontes MAP, Silva LCS, Neves LAA, Oliveira DR, Caligiorne SM, Rodrigues ARV, Gropen Jr C, Carvalho WS, Silva ACSE & Khosla MC (1994). Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors Brain Research Bulletin, 35: 293-398.
51. Burnier M, Pechere-Bertschi A, Nussberger J, Waeber B & Brunner HR (1995). Studies of the renal effects of angiotensin II receptor blockade: the confounding factor of acute water loading on the action of vasoactive systems. American Journal of Kidney Diseases, 26: 108-115.